


































Aging has different consequences in different tissues - it 
results for example in wrinkle formation of dermis, 
graying of epidermally-derived hair, loss of bone 
formation, myeloid bias of blood, and compromised 
function of the immune system [1]. Despite this wide 
spectrum of tissue specific age-associated changes the 
underlying molecular mechanisms might be related. 
Aging has been associated with accumulation of cellular 
defects such as DNA damage and telomere shortening. 
On the other hand, there is accumulating evidence that 
aging rather resembles a developmentally regulated 
process which is tightly controlled by specific 
epigenetic modifications [2-8]. 
 
Among epigenetic modifications, DNA methylation is 
best characterized. CpG dinucleotides in the 




































cytosines – and many studies demonstrated the 
occurrence of age-associated modifications in the DNA- 
methylation pattern [9-12]. Recently, this research 
gained further momentum by available technologies 
such as microarray platforms [13]. Among these the 
HumanMethylation27 BeadChip facilitates simul-
taneous analysis of 27,578 CpG sites which are 
associated with promoter regions of more than 14,000 
annotated genes [14]. Previously, we used this 
microarray for analysis of age-associated DNA 
methylation changes in mesenchymal stem cells (MSC) 
and fibroblasts [4,15,16]. Despite in vitro culture for 
several weeks these DNA-methylation profiles still 
reflected age-associated changes that relate to their 
donors, but this regulation differed markedly between 
MSC and fibroblasts indicating cell type specificity. 
Many other authors have used this platform to 
determine age-associated changes in primary tissues 
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Bocklandt et al. described a predictor of age for saliva 
samples which was generated by a dataset of 34 male 
twin pairs [22]. Based on three CpG sites associated 
with the genes neuronal pentraxin II (NPTX2), EDAR-
associated death domain (EDARADD) and target of 
myb1 (chicken)-like 1 (TOM1L1) they were able to 
predict donor age in independent saliva samples [22]. 
Overall, age-associated DNA-methylation changes are 
highly reproducible but most of them seem to resemble 
a tissue-specific phenomenon [12,23]. 
 
On the other hand, some age-associated DNA-
methylation changes do not appear to be tissue specific: 
Teschendorff and co-workers have identified a specific 
subset of 69 CpGs which are associated with polycomb 
group protein target genes and which revealed age-
associated changes – notably, they described similar 
modifications in seven independent data sets including 
normal and cancerous tissues as well as cultured MSC 
[21]. Furthermore, 10 CpG sites were overlappingly 
identified upon aging in saliva and blood samples 
[11,22]. It is conceivable, that such non-cell type 
dependent age-associated changes are of central 
relevance for the underlying process - and they might 
facilitate age-predictions in heterogeneous cell 
preparations. Therefore, we have combined several 
published DNA-methylation datasets to elaborate an 
Epigenetic-Aging-Signature which can be used for age-
predictions across different tissues. 
 
RESULTS AND DISCUSSION 
 
Selection of DNA-methylation datasets 
 
For this study, we have combined several datasets 
which were retrieved from public data repositories. We 
have only considered datasets that 1) used the same 
Infinium HumanMethylation27 BeadChip platform, 2) 
were generated with freshly isolated cells to exclude 
effects by culture expansion, 3) used non-cancerous 
material since malignant transformation might influence 
age-related changes, and 4) provided reliable 
information about donor age. DNA-methylation datasets 
of 13 different cell types or tissues were used: 5 datasets 
were implemented as a training-set for identification of 
the Epigenetic-Aging-Signature and 8 datasets were 
reserved for subsequent validation (table 1). For each of 
the 27,578 CpG sites the percentage of DNA-
methylation was provided as beta value ranging from 0 
to 1. Overall, the distribution of DNA-methylation level 
was similar in all samples of the training-set as 
determined by quantile analysis of beta-values. There 
was no clear association between global methylation 
level and donor age (Figure 1A). Several studies 
demonstrated that the global DNA-methylation level 
decreases upon aging [24-26]. However, the 
HumanMethylation27 BeadChip represents specific 
CpG sites which are predominantly associated with 
promotor regions and this might be the reason why 
global loss of DNA-methylation was not observed. 
 
Various CpG sites reveal age-associated hyper-
methylation 
 
Subsequently, we used Pavlidis Template Matching 
(PTM) [27] to identify CpG sites which correlated in 
their methylation level with donor age across the five 
datasets of the training-group. A template was specified 
according to the donor age (relative values between 0 
and 1) and the beta-values of each CpG site were then 
compared to this template to identify CpG sites with 
either continuous hypermethylation or hypomethylation 
upon aging (Pearson correlation). Initially, we used very 
stringent parameters with a regression coefficient R of 
more than 0.6 (corresponding to a p-value <10
-13). 19 
CpG sites passed this criterion – notably, all of them 
revealed hypermethylation upon aging (Figure 1B). 
These methylation changes might be influenced by the 
varying distribution of samples across age groups. To 
analyze if the 19 CpG sites also revealed age-associated 
changes within individual datasets we performed PTM 
analysis for each dataset separately and in most cases 
this resulted in a similar correlation (Table 2). 
Subsequently, we used a less stringent cut-off of R > 0.4 
(p-value <10
-5) resulting in age-associated 
hypermethylation at 431 CpG sites whereas 25 CpG 
sites were hypomethylated. This is in line with previous 
reports that demonstrated predominant 
hypermethylation at specific sites upon aging whereas 
hypomethylation might be less tightly regulated 
[11,21,22]. Taken together, several CpG sites revealed 
continuous age-associated methylation changes across 
all tissue types. 
 
Identification of the Epigenetic-Aging-Signature 
 
Next, we selected a subset of CpG sites to be integrated 
into the Epigenetic-Aging-Signature. Therefore, we have 
chosen CpGs which correlated with donor age across the 
whole training-set as well as in individual datasets. 
Another criterion was the variation in DNA-methylation 
level between young and elderly donors as larger changes 
are less prone to technical noise. Comparison of age-
predictions in the training set led us to four 
hypermethylated CpG sites corresponding to tripartite 
motif-containing 58 (TRIM58; cg07533148), KCNQ1 
downstream neighbor (KCNQ1DN; cg01530101), 
neuronal pentraxin II (NPTX2; cg1279989) and 
glutamate receptor ionotropic AMPA 2 (GRIA2; 
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more robust by additional consideration of a 
hypomethylated CpG site. Therefore, we have also 
included XIAP associated factor-1 (BIRC4BP; 
cg23571857) despite a lower correlation coefficient (R = 
-0.45; p = 9.76 x 10
-8). Selection of CpG sites was 
irrespective of gene function as it has been shown, that 
site-specific methylation changes are hardly associated 














































we observed age-associated hyper- and hypomethylation 
in the same promoter region – for example in 
KCNQ1DN (Figure 2). Notably, the epigenetic age 
predictor for saliva samples by Bocklandt and co-workers 
also included the CpG site corresponding to NPTX2 [22] 
and TRIM58 as well as GRIA2 were also included in 
their 88 age-related CpG sites. This overlap is remarkable 
since these authors used different bioinformatic methods 

















































































































































































fibroblasts  dermis  E-MTAB-202  20  18 - 72 yrs (44 yrs)  [17] 
keratinocytes  epidermis  E-MTAB-202  30  19 - 72 yrs (47 yrs)  [17] 
epithelial cells  cervical smear  GSE20080  30  26 - 43 yrs (32 yrs)  [21] 
CD4
+ T-cells  peripheral blood  GSE20242  24  16 - 69 yrs (35 yrs)  [11] 
CD14




saliva  GSE28746  71  21 - 55 yrs (35 yrs)  [22] 
leucocytes  peripheral blood  GSE20236  93  49-74 yrs (63 yrs)  [11] 
CD34
+ HPC  cord blood, 
peripheral blood 
E-MTAB-487  12  0 - 41 yrs (10 yrs)  [19] 
lymphocytes peripheral  blood  GSE23638  24  2 - 35 yrs (14 yrs)  [18] 
CB MNC  cord blood  GSE27317  168  0 yrs (0 yrs)  [20] 
whole blood  peripheral blood  GSE19711       274  52 - 78 yrs (65 yrs)  [21] 
breast tissue  breast organoid  GSE31979  15  46 - 68 yrs (53 yrs)  [28] 
buccal epithelial 
cells 
saliva  GSE25892   109  15 yrs (15 yrs)  [29] 
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analysis: the beta-values were plotted against donor age 
for all samples of the training-set (Figure 3A). Based on 
these equations we could inversely calculate donor age 
for each given beta-value. The mean of the five 
predictions of the Epigenetic-Aging-Signature was then 
















































CpG sites, the predictions correlated with an average 
precision of ± 9.3 years (Figure 3B). Alternatively, we 
focused only on three CpG sites with the most 
significant age-associated correlation (NPTX2, GRIA2 
and KCNQ1DN) – even this smaller subset facilitated 
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The Epigenetic-Aging-Signature was then tested on the 
eight independent datasets of the validation-group (Table 
1). To this end, we have only considered the five beta-
values which corresponded to the CpG sites of the 
Epigenetic-Aging-Signature. Each of these CpG sites 
revealed age-associated changes in analogy to the 
training-set (Figure 4A). The beta-values were then used 














































estimate the donor age. The predictions for donor age in 
the validation-group also correlated with the real age with 
an average precision of ± 12.7 years (Figure 4B). These 
predictions were even improved when we focused on the 
three most significant CpG sites of the signature 
(KCNQ1DN, NPTX2 and GRIA2) – then the average 
precision was ± 11.4 years (Figure 4C). For some 
individual datasets the precision was even less than 6 
years. Gender-related differences in the age-predictions 








































































































Epigenetic changes are a hallmark of aging - but it is yet 
unclear how these modifications are regulated [6]. 
DNA-methylation changes have been shown to be 
enriched in target genes of polycomb complexes [21] or 



















































demonstrated that long-term culture related DNA-
methylation changes in MSC are associated with 
repressive histone marks [2]. Thus, it may be speculated 
that protein complexes which are associated with the 






Gene Age-associated  R-values 
   all  samples 
of training 
group 








cg06572160 KCNC3  0.70  0.73 0.87  0.24  0.41  0.50 
cg07533148  TRIM58  0.69  0.68  0.76  0.35  0.38  0.52 
cg20616414 WNK2  0.67  0.66 0.87  0.31  0.32  0.33 
cg17861230 PDE4C  0.67  0.92 0.91  0.42  0.38  0.22 
cg25302419 CTNND2  0.67  0.65 0.68  0.33  0.59  0.55 
cg25802093 SPAG6  0.64  0.63 0.82  0.34  0.31  0.72 
cg06458239 ZNF549  0.63  0.88 0.85  0.15  -0.13 0.45 
cg27009703 HOXA9  0.63  0.66 0.90  0.29  0.30  0.56 
cg02844545 GCM2  0.63  0.75 0.77  0.35  0.66  0.47 
cg01683883 CMTM2  0.63  0.83 0.80  0.17  -0.18 0.21 
cg01530101  KCNQ1DN  0.63  0.91  0.67  0.16  0.33  0.45 
cg12799895  NPTX2  0.62  0.78  0.75  0.04  0.46  0.35 
cg21907579 TBX5  0.62  0.74 0.73  0.25  0.21  0.35 
cg00107187 FLJ42486  0.62  0.89 0.65  0.25  0.45  0.44 
cg16313343 BRF1  0.62  0.79 0.74  0.17  -0.12 0.25 
cg25148589  GRIA2  0.62  0.90  0.91  0.52  0.25  0.34 
cg23290344 NEF3  0.61  0.68 0.71  0.26  0.44  0.52 
cg02681442 FOXG1B  0.60  0.68 0.79  0.08  0.35  0.41 
cg03158400 FAM3B  0.60  0.71 0.70  0.37  0.13  0.66 
cg23571857  BIRC4BP  -0.45
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In this study we have identified an Epigenetic-Aging-
Signature consisting of five CpG sites which facilitates 
predictions of donor age across different tissue types. 
This method can for example be used in forensic 
analysis to estimate donor age of unknown tissue 
specimen including blood. It has to be noted, that 
chronological age is not identical with biological age 
and it is conceivable that some of the discrepancy 
between predicted and real age can be attributed to this 
difference – further research might facilitate 





DNA-methylation profiles used in this study. In this 
study we have considered all at the time publically 
available datasets with the Infinium 
HumanMethylation27 BeadChip platform in the public 
repositories Gene Omnibus (http://www.ncbi.nlm.nih. 
gov/geo; GPL 8490) and Array Express 
(http://www.ebi.ac.uk/arrayexpress; A-GEOD-8490). 
After literature search we decided to include the 
following 13 datasets for subsequent analysis which 
were divided in a training-group for identification of the 
Epigenetic-Aging-Signature and a validation-group. 
 
The authors of these important primary studies have to 
be acknowledged: Grönniger and co-workers isolated 
keratinocytes from epidermal suction blisters and 
dermal fibroblasts from punch biopsies (E-MTAB-202) 
[17]. Epithelial cells from cervical smear samples (19 
HPV negative controls, 11 HPV positive controls) were 
collected and analysed as described by Teschendorff et 
al. (GSE20080) [21]. Leucocytes, CD4
+ T-cells and 
CD14
+ monocytes were isolated from fresh venous 
whole blood as described by Rakyan and co-workers 
(GSE20242 and GSE20236) [11]. Saliva samples 
comprising buccal epithelial cells and leucocytes were 
collected as described in detail by Bocklandt et al. 
(GSE28746) [22]. CD34
+ hematopoietic progenitor 
cells (HPC) were isolated from cord blood and from G-
CSF mobilized peripheral blood as described by Bocker 
and colleagues [19] (E-MTAB-487; monocytes and 
granulocytes were not included to keep the cell 
specification homogeneous). Peripheral blood 
lymphocytes were isolated from whole blood as 
described in Chen et al. (GSE23638) [18]. Mononuclear 
cells were harvested by centrifugation of whole blood 
isolated from umbilical cord blood (GSE27317) [20]. 
Teschendorff and co-workers analyzed whole blood 
samples of healthy postmenopausal women 
(GSE19711) [21]. Normal breast organoids prepared by 
enzymatic digestion of reduction mammoplasty 
specimens were analyzed by Fackler et al. (GSE31979) 
[28]. Essex and colleagues determined DNA-
methylation profiles in saliva samples of fifteen-years-
old adolescents (GSE25892) [29]. Age ranges and 
sample numbers are summarized in Table 1. 
 
Combination of different datasets. Beta-values of the 
different datasets were combined by the reference ID of 
the Infinium HumanMethylation27 BeadChip platform 
(Illumina Inc., San Diego, CA, USA). These beta-values 
represent the percentage of methylation at each of the 
27,578 CpG sites – they are continuous variables 
between 0 and 1 and represent the intensity ratio of the 
methylated bead to the combined locus intensity. 
Background normalized raw data of these beta-values 
were determined with the BeadStudio software 
(Illumina) and retrieved from the public data 
repositories Gene Onmibus and Array Express. Initially 
we considered various normalization regimen including 
quantile normalization to minimize chip effects [30]. On 
the other hand, it is expected that methylation patterns 
vary between different cell tissues and this would be 
masked by such normalization regimen. Beta-values are 
less affected by normalization than the relative gene 
expression changes in mRNA microarray data. 
Furthermore, non-normalized beta-values are usually in 
line with validation experiments by pyrosequencing 
[4,14,15]. Therefore, we decided to use non-normalized 
raw-data for comparison over all data-sets. The 
combined data table of the training-set was 
subsequently analyzed using the MultiExperiment 
Viewer (MeV6.2) [31]. 
 
Identification of the Epigenetic-Aging-Signature. To 
identify CpG sites which reveal continuous age-
associated hypermethylation or hypomethylation we 
performed Pavlidis Template Matching (PTM) [27] 
with the MultiExperiment Viewer (MeV6.2) [31]. Each 
sample of the training-set was matched to a template 
with corresponding donor age. The combined dataset 
was then searched for CpG sites which correlated 
linearly in their beta-values with the donor age of the 
template (Pearson correlation) – initially we used very 
stringent criteria with R > 0.6. In analogy, each dataset 
was analysed separately and the overlap of age-
associated changes supported the notion that they occur 
in different tissues. Based on this analysis, we selected 
five CpG sites which revealed the best age-associated 
correlation across all 5 datasets of the training-set and 
relevant variation in the beta-values. For simplicity they 
were termed by their corresponding genes: TRIM58 
(cg07533148), KCNQ1DN (cg01530101), NPTX2 
(cg1279989), GRIA2 (cg25148589) and BIRC4BP 
(cg23571857). 
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regression analysis of beta-values versus donor age with 
EXCEL 2007 (Microsoft). These linear regression 
models were then used for age-predictions in the datasets 
of the training-group as well as for the validation-group: 
the five CpG sites (i) were inversely used to predict the 
age (N) by inserting the specific DNA-methylation levels 
of the corresponding CpG site (β). 
Ni = (β i - A i)/ B i   
Where A is the Y-axis intercept and B is the slope of the 
corresponding CpG site in the training group (Figure 
3A). The mean of the predictions of the five individual 
CpG sites of the Epigenetic-Aging-Signature was 
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